These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting]. Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408 [TBL] [Abstract][Full Text] [Related]
5. Psychiatrists, marijuana and the law: a survey. Lowinger P Med Trial Tech Q; 1974; 21(1):77-87. PubMed ID: 4420816 [No Abstract] [Full Text] [Related]
6. Statement of John Kaplan to the National Commission on Marijuana and Drug Abuse. Alaska Med; 1972 Jan; 14(1):17-9. PubMed ID: 5024269 [No Abstract] [Full Text] [Related]
7. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders]. Liraud F; Verdoux H Encephale; 2002; 28(2):160-8. PubMed ID: 11972143 [TBL] [Abstract][Full Text] [Related]
8. Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse. Jockers-Scherübl MC; Rentzsch J; Danker-Hopfe H; Radzei N; Schürer F; Bahri S; Hellweg R Neurosci Lett; 2006 Jun; 400(3):262-6. PubMed ID: 16540246 [TBL] [Abstract][Full Text] [Related]
9. [Mental state of the ill intoxicated with marijuana]. Vicuna MR Promot Dent; 1971; (14):28 passim. PubMed ID: 5290312 [No Abstract] [Full Text] [Related]
10. Contrasting models of genetic co-morbidity for cannabis and other illicit drugs in adult Australian twins. Agrawal A; Lynskey MT; Bucholz KK; Martin NG; Madden PA; Heath AC Psychol Med; 2007 Jan; 37(1):49-60. PubMed ID: 17076916 [TBL] [Abstract][Full Text] [Related]
11. Heavy cannabis users seeking treatment- prevalence of psychiatric disorders. Arendt M; Munk-Jørgensen P Soc Psychiatry Psychiatr Epidemiol; 2004 Feb; 39(2):97-105. PubMed ID: 15052390 [TBL] [Abstract][Full Text] [Related]
12. Marijuana: current medical knowledge and future directions. Scrignar CB J La State Med Soc; 1979 Aug; 131(8):205-7. PubMed ID: 114596 [No Abstract] [Full Text] [Related]
13. Propylhexedrine Intoxication: Clinical Presentation and Pharmacology. Liggett SB South Med J; 1982 Feb; 75(2):250-1. PubMed ID: 6120574 [No Abstract] [Full Text] [Related]
15. Marijuana as a trigger of cardiovascular events: speculation or scientific certainty? Aryana A; Williams MA Int J Cardiol; 2007 May; 118(2):141-4. PubMed ID: 17005273 [TBL] [Abstract][Full Text] [Related]
16. The addictive potential of cannabis. Kaymakçalan S Bull Narc; 1981; 33(2):21-31. PubMed ID: 6272922 [TBL] [Abstract][Full Text] [Related]
17. Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue? Budney AJ Addiction; 2006 Sep; 101 Suppl 1():125-33. PubMed ID: 16930169 [TBL] [Abstract][Full Text] [Related]
18. Clinical effects of marijuana on the young. Kolansky H; Moore WT Int J Psychiatry; 1972 Jun; 10(2):55-67. PubMed ID: 5082663 [No Abstract] [Full Text] [Related]
19. Clinical effects of marijuana on the young. Against hysteria. Zinberg NE Int J Psychiatry; 1972 Jun; 10(2):69-73. PubMed ID: 5082664 [No Abstract] [Full Text] [Related]
20. The pediatrician and the marijuana question. Dohner VA; Ott JE Pediatrics; 1970 Jun; 45(6):1039-40. PubMed ID: 5422108 [No Abstract] [Full Text] [Related] [Next] [New Search]